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Abstract
Problem Description: Polypharmacy in the frail elderly can lead to suboptimal management of
medical issues. Primary Care Providers (PCPs) often lack knowledge of best practices regarding
deprescribing and lack a systematic process for assessing mediation appropriateness. A quality
improvement project was developed and executed at Housecall Providers, a home-based primary
care practice in Portland, Oregon to facilitate the incorporation of deprescribing into daily
practice.
Interventions: Following a literature review, a curriculum was developed and utilized during an
educational intervention for PCPs regarding deprescribing best practices. A system for
introducing new PCPs to evidence-based deprescribing for the frail elderly. This information was
translated into materials that are now included in the PCP Handbook. A system for including
medication plans in the medical record was developed.
Results: The project showed positive impacts on PCP knowledge and confidence regarding the
deprescribing process. Results also demonstrated a strong commitment to practice change as a
result of interventions.
Interpretation: Polypharmacy and deprescribing educational efforts should be promoted in
primary care to help PCPs gain greater understanding regarding deprescribing best practices and
to help PCPs commit to needed deprescribing among their patient panels in order to improve
patient outcomes.
Conclusion: Future efforts to help promote safe, effective deprescribing should be a priority for
primary care practices. More research is needed on safe and effective deprescribing and policy
should follow the evidence as it emerges.
Key Words: deprescribing, polypharmacy, frail elderly
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Cultivating Appropriate Prescribing in a Primary Care House Calls Practice:
A Quality Improvement Project
The problem of polypharmacy in community-dwelling, frail older adults leads to multiple
issues including increases in adverse drug reactions, falls, disability, and mortality (Wang et al.,
2015), as well as poorer physical and mental capabilities (Rawle, Cooper, Kuh, & Richards,
2018). Despite general knowledge of the issue of polypharmacy, primary care providers (PCPs)
continue to prescribe potentially inappropriate medications (PIMs). PCPs at Housecall Providers
(HCP) lack knowledge of deprescribing best practices and lack a systematic process for
assessing mediation appropriateness.
Problem Description
Problem Background
Polypharmacy and PIMs have been recognized as barriers to optimal health care and
quality of life for older, frail, multimorbid patients. Page, Clifford, Potter, Schwartz, and
Etherton-Beer (2016) noted that by age 70, 75% of people take over five medications per day.
Polypharmacy is associated with poor health outcomes, increased frailty, increased geriatric
syndromes, and decreased health-related quality of life (Duncan, Duerden, & Payne, 2017; Page
et al., 2016; Saum et al., 2016; Sergi, De Rui, Sarti, & Manzato, 2011). Polypharmacy is also
associated with an increase in nonadherence, adverse drug reactions, drug-drug interactions, risk
of hospitalization, and costs (Rollason & Vogt, 2003).
The obvious solution to the problem of polypharmacy is to decrease the number of
medications the elderly receive. First mentioned in 2003, deprescribing has been defined as “the
process of withdrawal of an inappropriate medication, supervised by a health care professional
with the goal of managing polypharmacy and improving outcomes” (Reeve, 2015). Despite
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general knowledge of the issue of polypharmacy and the potential benefits of deprescribing,
PCPs continue to struggle with medication list optimization. Anderson, Foster, Freeman,
Luetsch, and Scott (2017) claimed that as many as one in five medications taken by the elderly
may be potentially inappropriate given age, frailty, comorbidity, and prognosis. Given this
complex milieu, many PCPs experience deprescribing as a daunting, time-consuming process
that produces confusion and anxiety.
Local Problem
HCP is a local primary care, palliative care, and hospice provider in Portland, Oregon.
HCP serves as primary care provider for over 1700 homebound individuals. These patients are
medically frail and often are nearing the end of life. Patients at HCP are prescribed an average of
11.4 scheduled medications. They often also have several as needed medications as well. During
informal interviews of PCPs at HCP, frustration over lack of clarity surrounding appropriate
prescribing practices and deprescribing was demonstrated. Overall, PCPs lack knowledge of
deprescribing best practices and lack a systematic method of bringing safe, evidence-based,
patient-centered deprescribing to patients. The above information has led to the following PICO
question for the Doctor of Nursing Practice Scholarly Project: For PCPs treating multimorbid,
community-dwelling adults experiencing polypharmacy, what are the best practices for safe
deprescribing?
Available Knowledge
Literature Review
Searches for evidence were performed in various databases in order to determine best
practice methods for deprescribing (see Appendix A). A total of 13 articles were reviewed for the
project. Overall, data available for deprescribing interventions remains in its infancy. Although
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data on the association between polypharmacy and poor outcomes is strong, there is not strong
data that prescription optimization efforts improve clinical outcomes (Potter, Flicker, Page, &
Etherton-Beer, 2016). However, the evidence supporting the safety of deprescribing is
consistently strong.
Available evidence shows deprescribing efforts do improve medication-related outcomes.
Deprescribing does result in fewer total medications as well as fewer PIMs (Huiskes, Burger, van
den Ende, & van den Bemt, 2017). Interventions with evidentiary support include physician
medication review, academic detailing, and the use of a structured deprescribing tool to assist
with assessment of medication appropriateness (Tjia, Velten, Parsons, Valluri & Briesacher,
2013).
Both explicit and implicit tools have some evidence for efficacy, however the explicit
tools have stronger evidence supporting their use. Evidence for implicit tools is currently less
robust; still utilization of implicit tools can help make PCPs’ think through a medication list in a
systematic way, evaluating each medication’s appropriateness given age, comorbidities, and
prognosis.
Synthesis of the Evidence
Evidence supporting deprescribing on clinical outcomes is young and the early evidence
has not shown a consistently favorable impact on clinical outcomes. However, it has been
suggested that the few studies that have been performed were not of sufficient size or duration to
detect a positive impact of interventions on clinical outcomes (Gokula & Holmes, 2012; Tjia, et
al, 2013). Further research is indicated in order to investigate the most efficacious tools to assist
with deprescribing. Still, the available evidence supports decreasing medication burden for
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elderly, frail patients given the improvements in medication appropriateness and the safety of
doing so.
Rationale
Theoretical Model
Donabedian’s 1966 model of Structure, Process, Outcome was utilized in the
development of the project structure and outcome goals (see Appendix B). The model asserts
that structures in healthcare affect the healthcare process, which affects outcomes for patients. In
this model, PCP knowledge is part of the structure of healthcare and this is the target of the
project intervention (Santana et al., 2017). It is posited, based on available evidence, that this
project intervention will affect the process of healthcare delivery (prescribing habits) and
therefore will positively affect patient-related outcomes. According to Santana et al. (2017), the
Donabedian model is key to providing patient-centered care and has played a central role in the
development of the patient-centered concept in healthcare.
Project Framework – Role of the Logic Model in Project Development
The logic model (Appendix C) was utilized in the development of this project. Based on
the Kellogg Foundation’s work, the logic model defined the theory-of-change that formed the
basis of the project. Outcomes were identified, and appropriate steps needed to achieve outcomes
were outlined. The logic model informed stakeholders of proposed resources, activities, and
outputs required in order to reach both short-term and long-term goals.
Specific Aims
This project aimed to create a standardized process through which PCPs working with
frail older adults can learn best practices in appropriate prescribing and to provide tools to assist
in the process of increasing medication appropriateness. The pilot intervention included an
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assessment of effectiveness based on participant feedback, pre/post testing, and PCP selfefficacy regarding the deprescribing process. In fulfillment of this aim, an educational
intervention and follow-up session were held to increase provider awareness of the problems
associated with polypharmacy. The session also provided PCPs with evidence-based tools to
help them with the process of prescription optimization for our patients. The provider education
will continue into the future in the form of a “train the trainer” session with the PCP team lead
who performs all onboarding educational functions. The information from the training is now
also included in the PCP handbook for future reference.
Context
The project setting is HCP. HCP is a non-profit primary care and hospice service in
Portland, Oregon that has been in existence since 1995. The mission statement of the
organization, according to the website (HCP, n.d.), is: “Improving lives by bringing health care
home.” Primary care services are carried out in patient homes across the city. HCP was acquired
by CareOregon in 2017 and is now a subsidiary of CareOregon. CareOregon is a non-profit
health plan that serves low-income Oregonians. CareOregon insures approximately one quarter
of all Oregon Health Plan members (CareOregon, 2014).
Population
The patients served by HCP tend to be some of the most ill members of our community.
On average, 25% of HCP patients die every year. Patients all meet the Medicare definition of
homebound. Homebound people, and especially homebound older adults, possess characteristics
which make them more vulnerable and marginalized than the non-homebound population.
People who are homebound have an average of twice as many chronic conditions as nonhomebound individuals (Ornstein et al., 2015). In general, they have lower incomes, less
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education, and poorer health status than non-homebound individuals (Musich, Wang, Hawkins,
& Yeh, 2015). The homebound also suffer more often from mental health issues such as
depression and memory impairment (Namkee, Sirey, & Bruce, 2013). Homebound individuals
are 15% less likely to be compliant with medication regimens and 9% less likely to comply with
recommended care patterns such as eye exams, annual visits, etc. (Musich et al., 2015).
Setting and Resources
The project took place in a home-based primary care (HBPC) practice. The model for
HCP practice includes longitudinal primary care services by visiting primary care providers. In
addition, a transition team comprised of registered nurses and social workers is deployed to help
facilitate movement between home and acute care settings. Palliative and hospice care teams are
also utilized when their services become beneficial for patients.
The project took place in the city of Portland, Oregon, which lies in Multnomah County.
Portland is the largest metropolitan area in the state. As a major metropolitan area, the city has
some challenges with social determinants of health for some members of the community,
although it tends to be a fairly wealthy city when compared to the rest of the state and country.
Unemployment is a low 4.7%. Despite a median income that is higher than the rest of the state,
Multnomah County has a higher percentage of people requiring public assistance income and a
higher rate of Medicaid recipients than the rest of the state. The county also has a high rate of
limited English proficiency at 9.15% of the population. Multnomah County tends to score well
on indicators of health behaviors and chronic disease burden (Community Commons, n.d.).
Relevant Elements of Project Setting
Serving approximately 1700 patients in the Portland metro area, HCP employs a team of
PCPs along with nurses, social workers, chaplain, and other support staff to help meet the needs
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of its patients. Total number of employees is approximately 100. Patients tend to be high-contact
and high-needs, requiring frequent interaction with their healthcare team. PCPs travel to patients’
location, whether a private home, adult foster home, assisted living facility, or memory care unit
and provide HBPC services. Each PCP cares for a panel of 100-140 patients. When appropriate,
primary care providers refer patients to a palliative care team of nurses, social workers and
chaplain who attempt to meet the increasing needs of patients as their diseases progress. Also
available to providers are an in-house pharmacist and psychiatrist specializing in geriatrics as
well as a robust set of volunteers.
While HCP is an official part of the CareOregon team, it continues to operate as a
separate nonprofit care delivery company. CareOregon’s mission of serving vulnerable
populations with creative solutions to people’s health needs is congruent with HCP’s history and
mission. CareOregon is a “safety net” nonprofit health plan whose members are often affected by
social determinants of health. They have approximately 200,000 Medicare/Medicaid members.
CareOregon, like HCP, is committed to patient-centered care of the underserved that takes the
entire individual into account (HCP, n.d.).
Organizational Culture and Readiness for Change
HCP has been an agile organization since its inception as changes in healthcare have
come about over the years. The acquisition by CareOregon has brought about a number of
changes in the structure and operation of the company. While the capacity to adapt at HCP is
high, there is a limit to the amount of change that can be absorbed by the employees. A concern
for change fatigue exists among staff and leadership. This could be a barrier to the effectiveness
of the intervention on clinical practice. In effort to combat change fatigue, the project utilized
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established weekly educational/meeting times. This helped by not placing increased burden on
PCPs as they were already accustomed to an educational component at this time.
Strengths and Weaknesses
Strengths of the pilot included an organizational culture which is dedicated to clinical
excellence. PCPs at HCP routinely engage in educational endeavors and clinical improvement
measures which are introduced in weekly primary care meetings. The pilot utilized this feature of
the practice to which PCPs were already accustomed. HCP also possesses a focus on continuous
improvement of practice and is accustomed to a collaborative approach to learning best practices.
Weaknesses of the project included PCP prescribing habits. Although PCPs have a
commitment to clinical excellence, many competing demands on time and attention throughout a
day can interfere with the focus and attention it may take to carefully consider patient medication
lists, especially when PCPs are novices at doing so. Experienced clinicians who have been
prescribing in a certain manner may find it taxing to refocus their attention on using their
prescription pads in a new way. Also, deprescribing requires conversations with family members
and education of families, patients, and caregivers, which can be time consuming.
Memorandum of Understanding
A memorandum of understanding was signed by HCP and the DNP student which
outlines both organizational and student commitment to the project (Appendix D).
Interventions
Interventions for the project began with the development of a curriculum to use for PCP
education. The curriculum was used to guide an educational session for PCPs and the pharmacist
at HCP. A pre/post-test was administered to measure knowledge gain and a commitment to
change (CTC) instrument was utilized. A follow-up session was held to discuss barriers to
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deprescribing and to troubleshoot solutions. Providers were also instructed on how to incorporate
the deprescribing plan into the EHR so that others involved in the care of the patient are clear on
the medication plan. Educational materials were also packaged for inclusion in the PCP
Handbook. A train-the-trainer session was held with the PCP onboarding trainer so that the
information was assured to carry forward to new employees.
Logic Model
A Logic Model served as the guiding logistical structure for the project and included
information on resources, activities and outputs needed to accomplish the following objectives:
1. Curriculum for educational session was developed and approved by medical director by
May 30, 2019.
2. By July 30, 2019 80% of HCP PCPs attended a deprescribing educational session.
3. PCP knowledge of the problems with polypharmacy and of evidence-based deprescribing
tools improved by 30% as measured by pre/post-test by August 30, 2019.
4. PCP self-efficacy surrounding the issue of appropriate prescribing increased by 20% as
measured by pre/post-test questions adapted from the EPIC scale by August 30, 2019.
5. PCP feedback on intervention was solicited and obtained via feedback form from 50% of
PCPs by September 30, 2019.
6. 80% of program participants completed the “Memo-To-Myself” as a commitment to
change measure by July 30, 2019.
7. “Train the trainer” program for one-on-one education with PCP trainer on appropriate
prescribing was developed and implemented by October 2019.
Intermediate-term Outcomes
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8. HCP PCPs are proficient with deprescribing tools outlined in the educational intervention
and are utilizing the tools to evaluate patient medication lists.
9. Mean number of routine patient medications on HCP patient medication lists, defined as
medications taken on a scheduled basis with no end date, decreases.
10. PCPs gained confidence in accomplishing appropriate prescribing tasks as they utilize
provided tools.
11. Feedback is synthesized, discussed among student, trainer, and pharmacist, and
incorporated into educational modules for future iterations of educational intervention for
appropriate prescribing.
12. PCPs implement changes in practice habits mentioned on their CTC.
13. New PCPs receive training on deprescribing as part of routine new PCP onboarding.
Long-term Outcomes
14. Patients achieve more appropriate medications, and as a result, better clinical outcomes.
15. PCPs critically evaluate all patient medications lists at least annually and with any
significant change in condition.
16. PCPs are confident and proficient with appropriate prescribing tools and utilize them with
appropriate patients on their panel.
17. Ongoing improvement of appropriate prescribing intervention.
18. Patients receive appropriate medications, and as a result, better clinical outcomes and
QOL.
Outcomes 1 through 7 were addressed within the timeframe of this project.
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Correlation of Interventions with the Theoretical Model Elements
The chosen interventions were designed to follow the Donabedian conceptual model of
quality improvement in healthcare. In this model, the staff training intervention is part of the
structure piece of healthcare delivery. By modifying the structure, that is, the knowledge and
tools available to PCPs, we can affect the PCP process of deprescribing and thereby affect
patient outcomes.
Timeline
The project timeline (see Appendix E) reflected anticipated needs for the project.
Important elements included curriculum development which occurred over the course of three
months in early 2019. Approval of curriculum was obtained in May 2019. Project
implementation and data collection occurred in Summer 2019 and data analysis was completed
Fall 2019. Dissemination of findings occurred Spring 2020.
Measures
Data measures were chosen to evaluate the effectiveness of the interventions in a local
practice setting. The Outcome Evaluation Table (Appendix F) details outcome measures. The
project was designed as a quality improvement project with the purpose of improving provider
prescribing practice and patient outcomes in one particular practice setting. Data gathered were
not intended to be generalizable.
Outcome 1
The first outcome was a process outcome which set a goal for the completion of training
materials with medical director approval by May 30, 2019.
Outcome 2
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Outcome 2 set a goal of 80% participation among HCP PCPs in the deprescribing
educational session. The data collected for this outcome was presented in the form of a training
report. The training report included the following elements: date of training, educational
objectives, educational materials provided, names of staff attendees, and aggregate scores on
pre/post-testing.
Outcome 3
Outcome 3 involved a pre/post-test (Appendix G). A pre/post-test design was utilized to
measure PCP knowledge gains as a result of educational intervention. This test included 5
multiple choice questions which were developed from curriculum materials with stakeholder
input. While more complex data collection may be desired by stakeholders in subsequent
iterations of the intervention, the pre/post-test provided initial evidence of the program’s efficacy
in achieving goals.
Outcome 4
Outcome 4 measured change in PCP self-efficacy surrounding the issue of appropriate
prescribing with a goal of a 20% increase in self-efficacy as measured by pre/post-test questions
adapted from the EPIC scale (Salback & Jaglal, 2011). The EPIC scale asks participants to rate
their level of confidence in performing different evidence-based medicine tasks. The scale is a
Likert-type scale. Three of the original 10 items from this tool were utilized and were included
on the pre/post-test.
Outcome 5
Outcome 5 set a goal of 50% response rate on an education program evaluation. Items
were selected from the Kirkpatrick Blended Evaluation Plan Samples (Kirkpatrick Partners, n.d.)
(Appendix H) and were customized according to stakeholder needs and goals. Items on the
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evaluation invited respondents to rate responses on a Likert scale. Qualitative data were also
collected on the PCP feedback form in the form of open-ended questions. The qualitative data
gathered from the feedback form were provided to stakeholders with information on which areas
of the educational module PCPs found most useful for their practice. Feedback was requested by
stakeholders to help inform future iterations of the education.
Outcome 6
Outcome 6 involved a CTC instrument called Memo-To-Myself (MTM). The MTM tool
was used following the educational intervention with a goal of 80% participation among program
participants. This portion of the evaluation was aimed at boosting the translation into practice of
the information conveyed in the educational intervention. The MTM tool asks participants to list
3 alterations in their clinical practice they will implement as a result of the educational
intervention. Participants filled out two identical MTMs. The first list was compiled into a master
list of commitments to change. This list served to guide discussion during the follow-up session
and was distributed to all PCPs 2 months following the follow up session as a reminder of
changes to which the practice committed. The second was placed in the PCP’s mailbox 6 weeks
following the education as a reminder of the individual PCP’s CTC.
Outcome 7
Outcome 7 was a process outcome which aimed to ensure the ongoing training of new
PCPs on appropriate prescribing. Typical training of new PCPs at HCP consists of 8 weeks of
one-on-one training with the PCP trainer. An appropriate prescribing class session, including
training on deprescribing tools, will be included in the future in this established training
schedule. In the train-the-trainer sessions, the PCP trainer was instructed on the materials created
for PCP training as well and the materials in the PCP Handbook. The sessions with the PCP
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trainer described the purpose of the intervention, explained materials, and answered
questions/concerns to ensure trainer confidence with the materials.
Budget
Anticipated total cost of the project for the first year was $7,230 with $4,550 donated in
the form the project manager’s time and equipment. The remaining portion of the budget,
totaling $2,680 was to be provided as an in-kind donation by HCP in the form of employee time
dedicated to the project, provision of meeting space, and via access to printing and copying
capabilities. Subsequent years have a much smaller budget for the updating of curriculum and for
ongoing training in appropriate prescribing, predicted to occur annually (see Appendix I). The
Expense Report details the actual costs of the project for the first year of implementation
(Appendix J). The Statement of Operations summarizes revenues and expenses (Appendix K).
Analysis
Outcome 1
Outcome 1 is a process outcome which did not involve analysis of data. Data reported on
this outcome involved a checklist of activities completed by a specified date.
Outcome 2
The analysis of this data occurred via a simple percentage calculation. Comparison
between actual participation and goal participation was made with the goal of quantifying the
number and percentage of staff participating in the group education component of the project.
Outcome 3
The pre/post knowledge test was analyzed utilizing descriptive statistics, which
summarized results from the pilot project educational intervention. The goal was for learners to
display a 30% knowledge gain post intervention. Comparison was made between the mean
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aggregated pretest scores and the mean post-test scores for each test item and was reported in the
aggregate to protect anonymity.
Outcome 4
Analysis of data collected via the EPIC scale questions was performed using descriptive
statistics. Median aggregated scores on each question were calculated and paired with pretest
scores to determine change in percentage, with a goal of a 20% increase in self-efficacy scores.
Scores were reported as aggregated scores for each item to assess port-test improvement.
Outcome 5
Data from the feedback form was compiled into a feedback report, which included
aggregated median scores by item for quantitative data and a list categorized by topic for each
qualitative question.
Outcome 6
Data analysis for this outcome included a calculation of the percentage of PCPs in
attendance at the education who completed the CTC, and a list of proposed commitments to
practice change created by PCPs, which was provided to stakeholders.
Outcome 7
Outcome 7 is a process outcome which did not involve analysis of data. Data reported on
this outcome involved a checklist of activities completed.
Ethical Considerations
Ethical Considerations and Protection of Participants
Ethical knowledge protects patient and family wishes while balancing care with
prognosis. Often in situations arising toward the end of life, conflicts arise between patient
wants/needs, family wants/needs, and PCP wants/needs. Some patients and/or families may not
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want to participate in the deprescribing process based on their own understanding and desires.
The PCP working with this population balances the social, emotional, and physical needs of the
patient while utilizing the ethical knowledge gained over a practice career (Moran, Burson, &
Conrad, 2017). Along the spectrum from full treatment to comfort measures lies a space for
reflection on the benefits and limits of medical care, and medicines often are the space where the
struggle of coming to terms with poor prognosis is played out.
No HIPAA protected data was used in the project. The data was collected anonymously.
Pre/post-tests were paired via a matching number system. Knowledge tests and surveys were
administered in the privacy of the participants’ office. Paper copies and answer key are kept in a
secure location accessible only to the project manager.
Biases
Potential biases could affect the application of knowledge gained through the project
interventions. One such bias involves a selection bias. It is possible that PCPs will select patients
on which to utilize the deprescribing tools who are seen as more cooperative or compliant than
other patients. Other possible selection biases may involve the ease with which permissions to
alter patient medication lists are obtained from legal healthcare representatives. Attempted
mitigation of these potential biases occurred through the educational focus on the dangers of
over/under prescribing, through an appeal to the PCPs’ sense of justice, and through emphasis on
the organizational commitment to providing excellent patient care.
Threats to Quality
Threats to the quality of this project included lack of PCP participation in the process of
deprescribing. Though the literature supports educational intervention, PCPs may have reasons
for not deprescribing which are not accounted for well in the available studies given the unique
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practice setting at HCP. The project success may have also been affected by PCP lack of time
and by change fatigue among PCPs.
Conflicts of Interest
The author has no conflicts of interest to report but is a PCP at HCP. CITI training was
obtained for this project (see Appendix L).
IRB Application and Project Determination
This quality improvement project was submitted to the Boise State University
Institutional Review Board for approval. Approval was obtained on April 22, 2019 via an
expedited review process (see Appendix M). The project followed the Belmont Report principles
for ethics in human research including respect for persons, beneficence, and justice (Harris,
Roussel, Dearman, & Thomas, 2016).
Results
Steps of the intervention were completed by August 2019. The results show mixed
success in achieving outcomes.
Steps of the Interventions
After receiving approval from stakeholders to proceed with the overall plan for the
intervention, a curriculum was developed in accordance with stakeholder needs and best-practice
evidence. Curriculum was reviewed by HCP pharmacist, PCP lead, and medical director. Minor
changes were made to the curriculum based on feedback and final approval of the teaching
materials was obtained. The initial education session occurred on June 20, 2019.
Evaluation tools were designed to measure the efficacy of the intervention and to meet
stakeholder needs. Applicable items from the EPIC scale were included as a measure of PCP
confidence in the deprescribing process. Out of 11 items on the original instrument, 3 were
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chosen as the most relevant to the project. These were included on the pre/post-test. Five
knowledge-based questions were also included in pre/post-testing to measure knowledge gain
from the educational intervention. These questions were developed by the project manager as a
quantitative measure of how the education affected PCP knowledge related to the education
objectives agreed upon by the stakeholders. The MTM was included in the intervention as a
measure of anticipated prescribing practice changes by PCPs.
As part of the sustainability of the project, in-house information technology and
electronic health records (EHR) specialists were consulted to establish feasibility and processes
by which deprescribing plans could be included in the EHR. A process was developed, and this
process was included during the demonstration portion of the educational intervention.
The initial education session occurred on June 20, 2019. Pre/post-tests were administered
the same day. A volunteer assisted with distribution and collection of tests which the project
manager left the room to help encourage PCPs to respond honestly. The whole session lasted 75
minutes including time for curriculum delivery, questions, and testing. Materials used during the
education were indexed in the shared drive for PCP reference in the future. In addition, printed
versions of the deprescribing tools were offered to PCPs who wanted them.
The follow-up session occurred on July 18, 2019. It included a discussion of what tools
PCPs have utilized in their practice and successes and barriers to doing so. Items listed on PCPs’
MTMs were also discussed.
Materials for the PCP Handbook were developed from the educational materials and were
approved in June 2019. The newly developed sections were added to the electronic version of the
PCP Handbook at that time and were indexed in the shared drive. This handbook serves as the
basis from which training of new PCPs occur.
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The train-the-trainer session occurred on August 15, 2019. PCP Handbook materials were
reviewed. Information regarding the dangers of polypharmacy was also reviewed and curriculum
for PCP onboarding was updated.
Details of the Process Measures and Outcomes
Outcome 1 – met. This process outcome was achieved with the completion and approval
of the curriculum for the educational portion of the project.
Outcome 2 – partially met at 98.8% of desired goal. This outcome set a goal of 80% of
PCPs participating in the initial educational session. There are currently a total of 19 PCPs at
HCP. A total of 16 PCPs were in attendance for a portion of the session. One PCP was only
present for a portion of the session and did not complete pre/post-testing. Another of the PCPs
was the project manager who ran the session. Fifteen PCPs were present for the entire session
making the percentage participating 79%. However, the clinic pharmacist and 2 non-PCP
providers also attended the presentation but did not complete pre/post-testing.
Outcome 3 – met. This outcome measured PCP knowledge gain through a series of 5
multiple choice questions. Goal for this outcome was a 30% increase in correct answers on
knowledge questions. Calculation of percent change in correct answers revealed a 56.7%
increase in correct answers (see Appendix N). The greatest knowledge gains occurred in the
areas of polypharmacy risk for older adults and evidence-based PIMs reduction strategies.
Outcome 4 – not met. Goal for this outcome was for PCPs to report a 20% increase in
confidence as measured by questions adapted from the EPIC scale. The actual percentage change
was 13.41%, which was 67% of desired goal (see Appendix O).
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Outcome 5 – not met. The goal for outcome 5 was to have 50% of PCPs complete a
session feedback form. Seven out of 15 participants completed the form for a 47% participation
rate, 94% of desired goal.
Outcome 6 – met. This outcome aimed to have 80% of PCPs participate in the CTC
process. Results revealed that 13 out of 15 participants completed the CTC instrument for a total
of 81% participation (see Appendix P).
Outcome 7 – met. This process outcome was completed in August 2019 and involved
training the PCP onboarding trainer on deprescribing materials as well as inclusion of those
materials in the PCP handbook.
Contextual elements interacted with the interventions in this project in several ways. The
first is the practice population. The vast majority of HCP patients are geriatric patients. Thus,
PCPs are de facto geriatricians who focus on care of older adults. As providers with this focus,
measures of pretest confidence and pretest knowledge may have been inflated when compared to
PCPs in general family practice. This likely deflated the change between pre and post-test
measures of both confidence and knowledge.
Another contextual element that may have interacted with the results of the intervention
is that the education was delivered by a colleague, potentially affecting measures of project
success and feedback. Had the education been delivered by an “expert” in deprescribing, there
may have been more buy-in from PCPs. Feedback was more limited than expected and may
represent a reluctance on the part of PCPs to provide constructive criticism to a peer presenter.
Another factor influencing the low rate of feedback is time constraints. PCPs often have visits to
make immediately following the education hour and may not have felt there was enough time to
provide constructive feedback
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The last contextual element that may have affected the project outcomes is the high level
of employee engagement in the organization. While this project was quite successful, a practice
with a lower level of employee engagement may be less successful. HCP PCPs are committed to
best practices care of patients as a top priority. As a mission-driven non-profit, there is less
emphasis on productivity and more emphasis on providing quality care. As such, education
regarding best practices tend to have more success in this setting than perhaps it would in a more
production-driven practice.
Missing Data
All paired pre/post-tests were collected and tabulated under the results section. There
were two unanswered pretest knowledge questions and one unanswered post-test knowledge
question, which were counted as incorrect answers.
Actual project revenues/expenses
The actual costs of the project differed from the budget in a few ways. The initial budget
for the project was $7,230 with $2,680 coming from HCP donation in the form of employee
salaries and $4,550 from donated project manager salary and equipment. The total actual cost of
the project was $8,270, for a difference of $1,040. The discrepancy between the budgeted
amount and the actual amount are the result of differences in the estimated and actual amount of
time needed to complete tasks, particularly the project management tasks. The PCP trainer
curriculum development and instruction in particular took longer than anticipated.
Summary
Results from the appropriate prescribing intervention revealed several positive outcomes.
Review of the literature resulted in the planning of an evidence-based intervention to increase
appropriate prescribing for frail older adult patients. Interventions chosen, based on available
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evidence, included physician medication review, academic detailing, and the use of structured
tools to assist in the deprescribing process.
As such, a deprescribing educational intervention was developed for PCPs at HCP, with
the goal of creating a set of standardized tools that PCPs at HCP can use which are evidencebased and relevant for our practice setting. Participation and engagement among PCPs was high.
PCP engagement was reflected in a high percentage increase in deprescribing knowledge.
However, increases in confidence measures were not as impressive, but may reflect high pretest
confidence given the practice setting and previous exposure to deprescribing efforts.
The MTM was quite successful both in terms of participation in the tool and in guiding
discussion during the follow-up session. The follow-up session was an important piece meant to
encourage translation into practice. Ratelle et al. (2017) describe reflection and CTC as key to
behavior change following continuing medical education modules. Revisiting the informationdense material presented in the initial education session via the follow up and MTM discussion
allowed a space for troubleshooting and encouragement among PCPs.
Interpretation
Overall, outcomes for the pilot project were positive. For the 16 participants in the
educational intervention, there was an increase of 56.7% in knowledge-based questions in
pre/post-test measurements. Knowledge of best practices has been shown to positively affect the
appropriateness of medications PCPs prescribe (Martin, Tamblyn, Bendetti, Ahmed, &
Tannenbaum, 2018).
As knowledge gain does not necessarily reflect practice change, the MTM was used to
help with the translation of the evidence into clinical practice. Such CTC instruments have been
shown to affect actual practice changes. Drawing on research regarding continuing medical
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education (CME), CTC instruments have been shown to enhance behavior change (White,
Grzybowski, & Broudo, 2004). Participation in the CTC among the program participants was
81% (n=13), indicating a high likelihood the PCPs will utilize their increased knowledge in
future prescribing decisions.
Ratelle et al., (2017) stated that early research regarding the effects of CME failed to
show meaningful improvement in practice and showed that critical reflection following CME
enhanced practice improvement. As such, the follow up session included discussion of
deprescribing successes and failures. Peers presented cases and group problem-solving
commenced. PCPs also shared clinical stories of improved health status for patients who have
undergone a deprescribing process. The follow-up was seen as quite valuable, particularly
because it afforded a space for PCPs to share knowledge and experience in clinical gray areas
where the research has not provided clear answers about best practice.
The EPIC scale was also utilized to assess the effectiveness of the intervention at
increasing PCP deprescribing confidence. This measure failed to meet the outcome goal of a
20% increase in deprescribing confidence. However, pretest report of confidence on
deprescribing tasks was an average of 8 on the 1-10 Likert confidence scale. It is possible that
the high pretest score is the result of PCPs’ familiarity with the concept of deprescribing due to
their focus on geriatrics and through previous education regarding deprescribing. The purpose of
including a measure of self-efficacy is that self-efficacy for particular tasks is linked with the
ability to perform that task and predicts the actual performance of that task (Salback & Jaglal,
2011). Those providers with higher self-efficacy beliefs surrounding a particular evidence-based
task are more likely to perform that task than those with lower self-efficacy (Salback, Jaglal, &
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Williams, 2013). Average post-test confidence scores were 9.05, indicating a high likelihood of
follow through on the part of the PCP.
Surrogate predictors of behavior change were utilized in the project because,
unfortunately, the current project was not able to measure the actual change in the number of
PIMs prescribed to HCP patients. Chart reviews were deemed too expensive to perform. Also,
the HIPPA requirements for such were not something stakeholders wished to tackle. In addition,
the changes desired in PCP prescribing will likely take more time to manifest in patient
medication lists than the duration of this project allowed.
Feedback was positive for the project (see Appendix Q). Average PCP scores on the
education’s relevance was 9.4 out of 10 and on helpfulness was 8.7 out of 10. Generally, PCPs
appreciated the introduction to the deprescribing tools. Feedback indicated that PCPs wanted
more time to discuss specific cases. This was suggested to the physician who runs routine bimonthly PCP roundtable discussions as a possible topic for future sessions. Anecdotally, the
most useful tool presented was medstopper.com. This is a Canadian web-based tool which is
evidence-based, easy to use, and provides patients and PCPs with a step-by-step path to
medication optimization. PCPs lamented that this valuable tool is not available with a focus on
drugs which are prescribed in the United States.
There are several relevant practice policy implications of the project. Given the
significant improvements in provider knowledge and commitment to appropriate prescribing,
HCP is planning to continue the deprescribing education. This is slated to occur annually and
will be run by the HCP pharmacist. It is also recommended that HCP consider a policy
expectation that PCPs complete a formal annual medication review for every patient. It is further
recommended that a medication plan be recorded annually during Medicare Annual Wellness

APPROPRIATE PRESCRIBING
30
Examinations under the ICD 10 code for medication management. Although a deprescribing plan
is not currently a required part of an Annual Wellness Exam, making this a part of the Annual
Wellness Exam would help to assure that deprescribing is considered for the majority of our
patients on an annual basis. A possible first step may be to have the nurse who already does the
Wellness Exam preparation and medication reconciliation also run the patient’s medication list
through medstopper.com. This way there is already a document which can help to facilitate a
conversation with patients and families regarding deprescribing. There is already a system in
place to save these reports into patient charts allowing PCPs access during home visits. However,
deprescribing is often an iterative process. Utilizing team nurses may help to decrease the PCP
follow-up burden at HCP.
At a national level, there is much that can be done to promote deprescribing and to
remove barriers which hinder deprescribing efforts. Deprescribing should be taught in
educational settings for future prescribers. A similar amount of educational effort should be put
into when to stop medications as is put into when to start them.
More broad health policy implications exist for the project. As we move to a value-based
health care system, inclusion of annual medication review in Medicare quality measures, such as
the Merit-based Incentive Program (MIPs) could help to incentivize consideration of
polypharmacy for older Medicare patients. Van Herck et al. (2010) note that there is a large body
of evidence that Pay for Performance programs increase effectiveness and quality of care. The
evidence shows that a provider medication review improves medication appropriateness. If
review of medication lists for appropriateness were included in the MIPs measures, providers
would be incentivized to complete a medication review. Eventually, more patients would begin
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to experience routine medication evaluations as Berdahl, Esterlin, Ryan, Needleman, and
Nuckols (2019) found that primary care practices tend to improve on MIPs measures over time.
Another strategy to increase incentive for PCPs to complete the often lengthy process of
making an appropriate prescribing plan could be to create a reimbursable CPT code specifically
for medication reviews. This strategy has been successful at increasing the number of Medicare
patient who have received counseling for advance care planning. Belanger et al. (2019) reported
that early evidence shows that the addition of the advance care planning CPT code increased
advanced care planning for patients. A similar CPT code addition has the potential to increase
utilization of medication list review.
Limitations
Several limitations of the pilot project are acknowledged. The results of this project are
not intended to be generalizable due to the design and purpose of the DNP quality improvement
project.
Other limitations include the unique practice setting in which the project occurred.
Because HCP is solely a HBPC setting, PCPs at HCP possess a unique set of skills and
knowledge gained from working solely in HBPC. The appropriate prescribing intervention may
be more or less effective in a traditional brick and mortar clinic setting due to a different
distribution of resources, different patient population, and different knowledge focus of PCPs. In
addition, the sample size for this project was small at 15 participants.
Another limitation of the results design include some threats to internal validity including
social desirability (Issel, 2014). Given that the delivery of the education was performed by a
peer, pre/post-test measures of confidence as well as the feedback may have been affected.
Efforts were made to mitigate this by having post-testing administered by a third party in the
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privacy of PCP’s offices. Also, the pre/post-test may not actually reflect all knowledge gained
through the education. Pre/post-testing only occurred before and after the formal education
intervention. No measures were included in the project to determine the effect of the follow-up
session where CTC was reiterated and reflective learning was more likely to have occurred. This
would be a suggestion for future iterations of the project.
Conclusions
Polypharmacy can be a barrier to optimization of health and well-being for older, frail
adults. Efforts to support deprescribing have been shown to increase medication appropriateness
and decrease PIMs. Although evidence on clinical outcomes remains scant, evidence of the
effect of deprescribing efforts on medication-related outcomes is solid, resulting in fewer
medications and fewer inappropriate medications. This project aimed to educate PCPs about
different tools available to them to assist in conversations with patients and families regarding
medications. These conversations are an important part of creating a comprehensive plan for
end-of-life care.
The project has proven useful for starting conversations among HCP PCPs. Discussions
about when to stop medications have been integrated into other routine educational activities on
an array of topics. For example, following a recent educational session regarding schizophrenia,
a discussion was held about dose tapering toward end of life. Discussion about balancing the
benefit of Sinemet for Parkinson’s with sedation associated in patients of advancing age was
similarly held during a question and answer period following a Parkinson’s educational session.
This anecdotal uptick in conversation around deprescribing speaks to the usefulness of the
project in putting these matters in the minds of PCPs as they go about their usual prescribing.
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Currently, the HCP pharmacist is taking on the responsibility of updating the
deprescribing educational materials annually and has agreed to lead an annual deprescribing
education and update. Organizational support at HCP for this has been demonstrated through
agreement to allot one of the weekly education sessions annually.
It is desired that this program will be expanded to include all pharmacists at CareOregon.
Discussion with stakeholders has been started about the feasibility of doing so. CareOregon has
recently announced an affiliation with Providence Health Systems, set to occur in the next 6
months. At this point it is unclear how the project would be affected by this new affiliation.
Given that energies in the organization are now focused on these upcoming changes, the future
project timeline is undecided. However, the affiliation with Providence will provide a broader
audience for future deprescribing efforts, since Providence employs a far greater number of
prescribers.
More research is needed in the field of deprescribing and PIMs. Large, high-quality
studies are needed to understand the effects of PIMs and deprescribing on clinical outcomes.
Those of us working in geriatrics know that often stopping medications has significant positive
effects on patient mentation, balance, and risk of hospitalization, but currently the evidence does
not back up this knowledge.
Trends in health care policy are putting a greater emphasis on the role of primary care.
Unfortunately, the money has not followed this trend and primary care providers continue to be
compensated at a much lower level than their specialist colleagues. This necessitates PCPs
continuing to see a high volume of patients, thus shortening appointment times. With an average
visit length of 17.5 minutes (Gilchrist, 2019), there is not time enough to do a thorough
medication review, discuss options with patients, and create a plan for the future. Pharmacist
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support may step into this gap to some extent. However, as we continue to move toward a valuebased system of reimbursement in health care, incentives for more attention to the issue of
polypharmacy may encourage PCPs to take the extra time to think critically about patient
medication lists while simultaneously considering prognosis and goals of care.
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Appendix A
Literature Review Summary Table
Johns Hopkins Nursing Evidence-Based Practice
Individual Evidence Summary Tool
Question: For PCPs treating multimorbid, community-dwelling adults experiencing
polypharmacy, what are the best practices for deprescribing?
Sample,
Sample
Size &
Setting

Author
# & Date

Eviden
ce
Type

Study findings that help
answer the EBP
question

1 Scott et
al.
(2017)

Narrati
ve
review

15 reports Structured guides better
on 7
at medication
algorithms optimization. Available
instruments: screening
criteria (Beers,
STOPP/START), risk
scales, clinical prediction
tools, and drug (or class)
specific guidelines

More
qualitative
research
needed

Level 2,
Quality C

2 Tjia et
al.
(2013)

System
atic
review

36 articles
(15 RCTs,
4 nonrandomize
d trials, 6
pre-post
studies,
and 11
case
series)

Systematic review of
different deprescribing
algorithms with summary
of evidence for each

Includes
some weak
studies, no
metaanalysis

Level 2,

3 Franke
nthal et
al.
(2014)

RCT

359
participant
s
(institutio
nalized)

Demonstrates efficacy of
STOPP/START to
improve appropriate
prescribing; provides
some data on secondary
outcomes such as cost,
falls, and hospitalization

Only
institutionali
zed
participants

Level 1,
Quality A

4 Ubeda
et al.
(2012)

Descrip
tive
study

81
residents

STOPP/START superior
to Beers in identifying
potentially inappropriate
prescribing

Small sample Level 2,
size
Quality C

Limitations

Evidence
Level &
Quality

Quality B
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Author
# & Date

Eviden
ce
Type

Sample,
Sample
Size &
Setting

Study findings that help
answer the EBP
question

Limitations

Evidence
Level &
Quality

5 Garfink Cohort
el &
study
Mangin
(2010)
6 Campin RCT
s et al.
(2016)

70
GP-GP shows good
participant results in communitys
dwelling older adults

Small sample Level 332,
size
Quality C

503
patients

Not blinded

Level 1,
Quality A

7 Garfink
el et al.
(2007)

Cohort
study

119
GP-GP reduced
participant medications, improved
s
mortality, lowered costs,
and improved QoL

Nor RCT

Level 2,
Quality C

8 Page et
al.
(2016)

System 132
atic
papers
review
and
metaanalysis

Mortality not affected by
deprescribing in RCTs,
mortality reduced when
patient-specific
interventions applied

Often not
comparing
apples to
apples

Level 2,
Quality A

Level 1,
Quality A

Improvement in
appropriate prescribing.
No improvement in ER
visits, hospitalizations, or
death

9 Huiskes System
(2017) atic
review

31 RCT

Medication review
improve medication
appropriateness but had
little effect on clinical
outcomes

Lack
evidence of
effects

1 Potter
0 et al.
(2016)

47 older
adults

Education intervention
decreases number of
medication but had little
effect on secondary
outcomes

Small sample Level 1,
size
Quality B

RCT
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Appendix B
Theoretical Model
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Appendix C
Logic Model Table
Resources/Inputs

Activities

Outputs

Outcomes: Short term

Outcomes:
Intermediate

Outcomes: Long
term

What we invest:
resources and
contributions

What we do

What we
accomplish
or produce
from the
activities

Who we reach
with our
activities

The expected
changes attainable
during the DNP
Scholarly Project
timeline.

The expected
changes attainable 6
months - 2 years
after the DNP Project
is implemented.

Fundamental
changes for
participants or
community because
of project activities,
3-5 years after
project
implementation.

The human,
financial,
organizational,
and community
resources available
to direct toward
the project
activities.

The processes,
tools, events,
technology, and
actions that are
intended to
bring about
changes

Direct
products and
services
generated
from program
activities

Intended targets
of the program
services and
activities

Specific changes in
program. SMART.

Specific changes in
program. SMART.

Represent changes in
knowledge, attitude,
or beliefs

Represent changes
in behavior or
actions

Represent changes
in status, condition
or well-being.
Consider: health
impacts, economic
impacts,
environmental
impacts, societal
impacts.

-time for
development of
curriculum
-medical director
time for review

(1) Curriculum for
educational session
was developed and
approved by medical
director by May 30,
2019. (PO)
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-PCP time
-PCP attention
-AV equipment
-Use of weekly
PCP didactic time
x2 weeks

-Test run to
assure
technology
working
optimally for
classroom
delivery of
material

PCPs at HCP
spend 2 hours
(total)
receiving
instruction on
deprescribing
tools

PCPs

(2) By July 30, 2019,
80% of HCP PCPs have
completed
deprescribing
educational session
and/or follow-up
session. (PO)

(8) HCP PCPs are
proficient with
deprescribing tools
outlined in the
educational
intervention and are
utilizing the tools to
evaluate patient
medication lists. (CO)

(14) Patients achieve
more appropriate
medications, and as a
result, better clinical
outcomes. PCPs
critically evaluate all
patient medications
lists at least annually
and with any
significant CIC.

PCPs at HCP
spend 3 hours
(total)
receiving
instruction on
deprescribing
tool

PCPs

(3) PCP knowledge of
the problems with
polypharmacy and of
evidence-based
deprescribing tools
will improve by 30%
as measured by
pre/post-test by
August 30, 2019. (CO)

(9) Mean number of
routine patient
medications on HCP
patient medication
lists, defined as
medications taken on
a scheduled basis with
no end date,
decreases. (CO)

(15) PCPs critically
evaluate all patient
medications lists at
least annually and
with any significant
change in condition.

-Teach classes
(during
established PCP
didactic time)
on optimizing
prescription
appropriateness

-PCP time
-PCP didactic hour
on TBD date(s)
-PCP attention

Teach classes
(during
established PCP
didactic time)
on optimizing
prescription
appropriateness
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-PCP time
-copies of form
-time for synthesis
of information

-Solicit selfefficacy rating
via modified
EPIC following
intervention
-Synthesize
information
provided by
PCPs

-PCP time
-copies of form
-time for synthesis
of information
-trainer time for
review

-PCP time
-copies of form
-time for synthesis
of information

-Solicit
feedback
following
intervention

Report to
stakeholders
indicating
mean change
in PCP selfefficacy

PCPs

Synthesis of
PCP feedback
on
intervention

PCPs

Report to
stakeholders
of percentage
completed and

PCPs

Stakeholders

Trainer
Pharmacist

-Synthesize
information
provided by
PCPs on PCP
feedback form

-Solicit
feedback
following
intervention

Stakeholders

(4) PCP self-efficacy
surrounding the issue
of appropriate
prescribing increased
by 20% as measured
by pre/post-test
questions adapted
from the EPIC scale by
August 30, 2019. (CO)

(10) PCPs gained
confidence in
accomplishing
appropriate
prescribing tasks as
they utilize provided
tools. (CO)

(16) PCPs are
confident and
proficient with
appropriate
prescribing tools and
utilize them with
appropriate patients
on their panel.

(5) PCP feedback on
intervention was
solicited and obtained
via feedback form
from 50% of PCPs by
September 30, 2019.
(PO)

(11) Feedback is
synthesized, discussed
among student,
trainer, and
pharmacist, and
incorporated into
educational modules
for future iterations of
educational
intervention for
appropriate
prescribing by
November 2019. (CO)

(17) Ongoing
improvement of
appropriate
prescribing
intervention.

(6) 80% of program
participants will
complete the “MemoTo-Myself” as a
commitment to change

(12) PCPs implement
changes in practice
habits mentioned on
their CTC. (CO)

(16) PCPs are
confident and
proficient with
appropriate
prescribing tools and
utilize them with
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-Trainer time
-Evaluation of
current literature
-Organizational
support for trainer
time

-Synthesize
information
provided by
PCPs

list of
responses.

-Create “train
the trainer”
materials to
supplement and
augment
material
created for PCP
onboarding

New PCP
didactic
materials on
appropriate
prescribing
which are
appropriate to
a one-on-one
setting for the
PCP trainer to
utilize in
routine
onboarding
didactic
training

-Discuss aspects
of teaching
which will be
included in
routine PCP
onboarding

measure by July 30.
2019. (CO)

appropriate patients
on their panel.

CTC
reminders to
PCPs as well
as aggregated
list distributed
to all PCPs.

Trainer
Future PCPs

(7) “Train the trainer”
program for one-onone education with
PCP trainer on
appropriate
prescribing was
developed and
implemented by
October 2019. (PO)

(13) New PCPs receive
training on
deprescribing as part
of routine new PCP
onboarding. (PO)

(18) Patients receive
appropriate
medications, and as a
result, better clinical
outcomes and QOL.
PCPs critically
evaluate all patient
medications lists at
least annually and
with any significant
CIC.

Adapted from: Logic Model Foundation Development Guide, pg 4.
http://www.wkkf.org/resource-directory/resource/2006/02/wk-kellogg-foundation-logic-model-development-guide
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Appendix D

APPROPRIATE PRESCRIBING
48
Appendix E
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Timeline
2018
1

2

2019
3

4

5

6

7

8

9

10

11

12

1

PLANNING
Lit Review, mission, vision,
problem statement
Timeline
Project Logic Model
Complete project proposal
IMPLEMENTATION
Create curriculum
Meeting with pharmacist
Curriculum approved by
medical director
Create PCP pre/post tests
Teach workshop and follow
up on deprescribing
DATA COLLECTION
Collect pre/post data
(average number of
prescriptions)
Collect pre/post-tests
DATA ANALYSIS
DISSEMINATION

Write final report
Final Report

Appendix F

2

2020
3

4

5

6

7

8

9

10

11

12

1

2

3

4

5
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Outcome Evaluation Table

Outcome

Data Collection Instrument / Data

(1) Curriculum for
educational session was
developed and approved
by medical director by
May 30, 2019.

Data collection will include a checklist of tasks to be
completed.

n/a

n/a

(2) By July 30, 2019,
80% of HCP PCPs have
completed deprescribing
educational session
and/or follow-up
session.

Instrument: A training report submitted to HCP
medical director, which includes the following
elements:
Date of training
Educational objectives
Educational material included in the module
Names of staff attendees
Scores of staff attendees

To quantify the number
and percentage of staff
participating in the group
education component of
the project.

Report provides
data for
determining
nominal count and
percentage of staff
participation in the
group education
intervention.
Comparison
between actual
participation and
goal participation
allows comparison
between goal and
actual participant
numbers.

Data: The training report will include data regarding
PCP participation to include date of training,
educational objectives, educational materials
provided, and names of staff attendees.

Analysis Goal

Analytic
Technique
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(3) PCP knowledge of
the problems with
polypharmacy and of
evidence-based
deprescribing tools
presented improved by
30% as measured by
pre/post-test by August
30, 2019.

Instrument: A pre/post-test design will be utilized to
measure PCP knowledge gains as a result of
educational intervention. The test will measure the
same information from the same group at two
different points in time. The pretest will occur before
the session and the post-test will occur at the end of
the session. The test will include knowledge-based
questions which will be based on program content.

To quantify PCP
knowledge gain
surrounding the issue of
polypharmacy and to
quantify PCP proficiency
with deprescribing tool.

Descriptive
statistics: median
scores will be
calculated on both
pre and post-test.
Goal is for learners
to display a 30%
knowledge gain
post intervention on
the post-test.

To measure the increase
of PCP self-efficacy in
terms of deprescribing as
a predictor of actually
carrying out deprescribing
tasks.

Anonymous paired
scores will be
analyzed to
discover the mean
change in PCP
perceived selfefficacy.

Data: Paired pre/post-test data will be tabulated for
each test item to provide a mean difference in
knowledge gain.
(4) PCP self-efficacy
surrounding the issue of
appropriate prescribing
increased by 20% as
measured by pre/posttest questions adapted
from the EPIC scale by
August 30, 2019.

Instrument: Included in the knowledge pretest will
be 3 questions adapted from the Evidence-Based
Practice Confidence (EPIC) scale (Salbach & Jaglal,
2010) which are designed to measure PCP selfefficacy in utilizing evidence-based practice.
Instrument includes Likert-type questions asking
participants to rate their confidence in performing
deprescribing tasks. Self-efficacy will be retested at
the end of the follow-up session.

Data: Mean self-efficacy scores will be calculated for
each PCP participant on both pre and post-tests.
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(5) PCP feedback on
intervention was
solicited and obtained
via feedback form from
50% of PCPs by
September 30, 2019.

Instrument: A post-intervention feedback form of
PCP participants following educational intervention
utilizing items selected in conjunction with
stakeholders from Kirkpatrick Blended Evaluation
Plan as well as open ended questions.

Data: Questions will focus on the most/least helpful
elements of the educational intervention and will ask
about ongoing gaps in knowledge.
(6) 80% of program
participants will
complete the “MemoTo-Myself” as a
commitment to change
(CTC) measure by July
30, 2019.

Instrument: Memo-To-Myself (MTM) completed by
program participants and collected from participants
following education. Instrument includes 3 blank
lines and asks participants to list 3 alterations in
clinical practice they will implement in their practice.
Memos will be anonymous. Participants will fill out
two identical MTMs and will place one in an
envelope with their name on it and seal it. This will
be delivered to each participant 3 weeks following
the education as a reminder of their CTC. After 6
weeks, a list of items on all participants’ MTMs will
be distributed to all.

Data: Data gathered will include percentage of
participants who complete the MTM. Will also

To understand what type
of information PCPs at
HCP already possess and
to understand where gaps
in knowledge might
persist in order to improve
the quality of education
surrounding the topic of
appropriate prescribing.

Data will be
categorized and
presented in list
form to
stakeholders. Data
will be aggregated
and categorized by
frequency of
responses.

1. To provide
percentage of
completion as
evidence of
participant
engagement in
intervention.

Percentage
calculated from
aggregate number
of MTM forms
received from PCP
participants. Also
will include list of
participant
responses with
enumerated list of
participant
responses.

2. To provide
stakeholders
qualitative data
regarding the
impact of the
intervention on
PCP practice.
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provide stakeholders with aggregated list of items on
PCPs’ MTMs.

(7) “Train the trainer”
program for one-on-one
education with PCP
trainer on appropriate
prescribing was
developed and
implemented by October
2019.

Instrument: PCP handbook to include new materials
developed. Session with PCP trainer to describe
purpose of the intervention, explain material, and
answer questions/concerns. Additional sessions
completed as necessary to ensure trainer confidence
with material. Appropriate prescribing class session
incorporated into the new PCP training schedule.

Data: Feedback on material will be solicited and
handbook material will be edited based on feedback
from medical director, pharmacist, and trainer.

Derived from W.K. Kellogg Foundation Logic Model Development Guide.
http://www.wkkf.org/resource-directory/resource/2006/02/wk-kellogg-foundation-logic-model-development-guide
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Appendix G
Pretest Questionnaire
Participant number _______
Participation in this activity is voluntary. All responses are anonymous.
1. How confident are you in your ability to ask your patient or family about needs, values, and
treatment preferences as relates to potentially inappropriate medications (PIMs) (circle one).
(least confident) 1
2
3
4
5
6
7
8
9
10 (most confident)
2. How confident are you in your ability to decide on an appropriate course of action based on
integrating research evidence, clinical judgement, and patient preferences?
(least confident) 1
2
3
4
5
6
7
8
9
10 (most confident)
3. How confident are you in your ability to continually evaluate the effect of your course of
action on your patient’s outcomes?
(least confident) 1
2
3
4
5
6
7
8
9
10 (most confident)
4. Which are known reasons why older adults are more at risk of problems with polypharmacy
(circle all that apply)?
a. homeostenosis
b. memory problems
c. pharmacokinetics
d. pharmacodynamics
e. swallowing problems
5. Polypharmacy contributes to increases in which of the following (circle all that apply)?
a. nonadherence
b. interactions
c. adverse reactions
d. hospitalizations
e. cost
f. frailty
g. geriatric syndromes
h. mortality
6. The “prescribing cascade” refers to:
a. The practice of using two medications to treat a particular disease when one would
work just as well.
b. The practice of treating drug side effects with the use of another drug.
c. When prescribers are not aware of which drugs have been prescribed and add other
prescriptions that may have unsafe interactions.
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d. The practice of prescribing more medications based on a patient’s demand or
expectation.
7. Potentially inappropriate prescribing (PIP) means: (circle all that apply)
a. Medications that are prescribed at inappropriate doses.
b. Medications that have increased side effects for a particular patient population.
c. Medications identified on the BEERs list.
d. Medications that have potential risks higher than potential benefits.
e. Medications that should be prescribed given patient diagnosis.
8. The evidence shows that which of the following are effective at reducing PIMs? (circle all that
apply)
a. Using a deprescribing tool.
b. Prescriber education.
c. Prescriber review of medications.
d. Prescriber feedback.
e. Pharmacist medication review.
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Appendix H
Feedback Form
This education is relevant and applicable to my work

What I learned will help me in my work.

The most important/useful thing I learned was:
______________________________________________________________________________
______________________________________________________________________________
What additional information do you suggest be added to the program?
______________________________________________________________________________
______________________________________________________________________________
What information do you suggest be removed from the program?
______________________________________________________________________________
______________________________________________________________________________
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Appendix I
3-Year Budget
Revenues

HCP in-kind contribution
Salaries

HCP in-kind contribution
Administrative Supplies
DNP in-kind contribution
Project Manager
DNP in-kind contribution
Educational Intervention
DNP in-kind contribution
Evaluation and
Assessment
DNP in-kind contribution
Train the Trainer
DNP in-kind contribution
Computer and software
Total
Expenses

Year 1

Year 2

Year 3

$ 2,595

$ 1,185

$ 1,185

$ 85

$ 40

$ 40

$ 2,400

$ 180

$ 180

$ 120

$ 60

$ 60

$ 900

$ -

$ -

$ 480

$ -

$ -

$ 650

$ -

$ -

$ 7,230
Year 1

$ 1,465
Year 2

$ 1,465
Year 3

Planning - Project
Manager/Educator

$ 2,400

$ 180

$ 180

Planning - Pharmacist

$ 120

$ 60

$ 60

Planning - Medical
Director

$ 200

$ 100

Rationale
This is a subsidized program
with no anticipated
organizational revenue, though
project is anticipated to improve
measures of quality which have
the potential to improve
reimbursements.

$ 100

Year 1 estimate includes 40
hours at $60/hr for literature
review, development of
curriculum, and meetings to
collaborate with organizational
stakeholders. Estimate for years
2 and 3 for 3 hours at $60/hr to
review new literature and make
updates based on new evidence
and changes in organizational
needs.
Year 1 estimate includes 2 hours
at $60/hr for collaboration with
PM and review of curriculum.
Estimate for years 2 and 3 for 1
hour at $60/hr to review
curriculum updates.
Year 1 estimate includes 2 hours
at $100/hr for collaboration with
PM and review of curriculum.
Estimate for years 2 and 3 for 1
hour at $100/hr to review
curriculum updates.
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Planning - Quality
Manager

$ 100

$ 50

$ 50

Year 1 estimate includes 2 hours
at $50/hr for collaboration with
PM on project alignment with
organizational quality goals and
organizational reporting needs.
Estimate for years 2 and 3 for 1
hour at $50/hr to review
curriculum updates and inform
educator on organizational
quality reporting needs.

Educational Intervention
- PCPs

$ 1,800

$ 900

$ 900

Estimated 2 hours for 15 PCPs at
$60/hr for the first year and 1
hour for subsequent years.

$ 60

Year 1 estimate includes 2 hours
at $60/hr to deliver educational
materials to PCPs. Years 2 and 3
estimate includes 1 hour at
$60/hr to deliver
update/refresher education.

Educational Intervention
- Project
Manager/Educator

$ 120

Educational Intervention
- Meeting room rental

$ 60

Evaluation &
Assessment

$ 900

Train the Trainer Project Manager

$ 480

Train the Trainer Clinical Lead

$ 375

$ 60

$ 30

$ 30

$ 75

$ 75

Year 1 estimate includes 2 hours
of meeting space rental at
$30/hr. Years 2 and 3 estimate
includes 1 hour at $30/hr.
Based on $60/hr for an
estimated 15 hours in order to
administer pre/post surveys,
compile and analyze data. Not
anticipated to be an ongoing
expense.
Year 1 estimate includes 8 hours
at $60/hr to create clinician
handbook materials, participate
in "train the trainer" sessions,
collaborate with clinical lead on
handbook materials. Not
anticipated to be an ongoing
expense.
Year 1 estimate includes 4 hours
at $75/hr to review and
collaborate with project
manager on curriculum,
participate in "train the trainer",
review clinician handbook
materials. Years 2 and 3
estimate includes 1 hour at
$75/hr to provide training to
new PCPs.
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Administrative Supplies
& Support

$ 25

Computer and software
(in kind)

$ 650

Subtotal Expenses
Less DNP in kind
contribution
Inflation adjustment
(2.2%)
Total Organizational
Contribution

$ 7,230

$ 10

$ 10

$ 1,465

$ 1,497

$ 32.23

$ 32.94

$ 1,497

$ 1,530

Cost estimate for printing,
copying, toner, pens, staples,
other general office supplies to
include handouts for providers,
copies of surveys, copies of
materials for PCP handbook, and
copies of reports to
stakeholders. Decreased cost in
years 2 and 3 because of
decreased copying/printing
involved in subsequent years
since approvals will be
completed and because of less
rigorous pre/post testing.
One-time expense. Cost
estimate via Office Depot
website.

$ (4,550)

$ 2,680

Note: Table format adapted from Boise State University NURS 622 course material in module 3 by T. Serratt,
2018. Inflation rates estimated to be an average of 2.2% over the next 3 years. The national inflation rates were
taken from Statista (2016), Projected Annual Inflation Rate int he United States 2010-2023, Statistica web site:
https://www.statista.com/statistics/244983/projected-inflation-rate-in-the-united-states/
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Appendix J
Expense Report (actual)
Source of Expense

Estimated
Volume

Expense
Per Unit

per hour

44 hrs

$60

Variable

per hour

2 hrs

$60

$200

Variable

per hour

2 hrs

$100

$75

Variable

per hour

1.5 hrs

$50

Printing and copying

$10

Fixed

100

0.1

Computer and software

$650

Fixed

1

Expense Description

Planning

Project Manager

Pharmacy
Medical director

Quality manager

Administrative Supplies

Dollar
Value

Type of
Cost

Description
of Cost

$2,640

Variable

$120

Cost
Create curriculum
materials, meet with lead,
pharmacist, and medical
director to discuss
curriculum and gain
approvals
Review and collaborate
with PM on curriculum
Review and collaborate
with PM on curriculum
Meet to discuss alignment
with organizational quality
initiatives and plan
stakeholder reporting

Total
Education Intervention

$3,695
Cost

PCP Salaries

Salary for 15 providers x 2
hours for educational
intervention

$2,010

Variable

$60/hr x
33.5 total
hours

30 hrs

$60

Pharmacy
Project Manager

Attend sessions
Teach education session

$120
$120

Variable
Variable

per hour
per hour

2 hrs
2 hrs

$60
$60

Meeting room rental

Rental of meeting room

$60

Fixed

Room
rental rate

2 hrs

Administrative supplies

Printing and copying of
handouts and surveys

$15

Fixed

Total
Evaluation/Assessment

Evaluation &
Assessment

150

$30/hr
0.1

$2,325
Cost

Compilation and analysis
of pre/post-test, program
evaluation, data
entry/analyses,
presentation to
stakeholders

$1,320

Variable

$60/hr x 15
total hours
for Project
Manager

22 hrs

$60
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Total
Train the Trainer

Project Manager

Clinical Lead

Create clinician handbook
materials, participate in
"train the trainer"
sessions, collaborate with
clinical lead on handbook
materials
Review and collaborate
with project manager on
curriculum, participate in
"train the trainer", review
clinician handbook
materials
Total
Grand Total

$1,320
Cost

$480

Variable

per hour

8 hrs

$60

$450

Variable

per hour

6 hrs

$75

$930
$8,270
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Appendix K
Statement of Operations
Revenues
DNP in-kind

$

4,550

$

2,680

$

7,230

$

85

$
$
$

650
3,900
2,595

Total $

7,230

HCP contribution (This is a subsidized
program without anticipated organizational
revenue.)
Total
Expenses
Administrative supplies/support, meeting
space
Computer and software
Project management salary
Clinic staff salaries

Operating Income

$

-
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Appendix L
CITI Training Certificate

APPROPRIATE PRESCRIBING
64
Appendix M
Scholarly Project IRB Approval Letter or Letter of Determination
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Appendix N
Knowledge test results
Question 7
Pretest score: average 78%
Post-test score: average 100%
Percent improvement: 28%

Question 4
Pretest score: average 45%
Post-test score: average 78%
Percent improvement: 73%

Question 8
Pretest score: average 38%
Post-test score: average 87%
Percent improvement: 129%

Question 5
Pretest score: average 32%
Post-test score: average 66%
Percent improvement: 34%

Total average percent improvement: 56.7%
Question 6
Pretest score: average 81%
Post-test score: average 96%
Percent improvement: 15%

Percentage Correct
100%

96%

87%

81%

78%

78%

66%
45%

49%

QUESTION 4

QUESTION 5

38%

QUESTION 6
Pretest

Post-test

QUESTION 7

QUESTION 8
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Appendix O
EPIC Results
1. How confident are you in your ability to ask your patient or family about needs, values, and
treatment preferences as relates to potentially inappropriate medications (PIMs) (circle one)
Pretest score: average 8.14
Post-test score: average 9.07
Percent improvement: 11.43%
2. How confident are you in your ability to decide on an appropriate course of action based on
integrating research evidence, clinical judgement, and patient preferences?
Pretest score: average 7.86
Post-test score: average 9.12
Percent improvement: 16.39%

3. How confident are you in your ability to continually evaluate the effect of your course of
action on your patient’s outcomes?
Pretest score: average 8.00
Post-test score: average 9.00
Percent improvement: 12.5%
Average percentage change 13.41%
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Appendix P

Commitment to change list
I will use a tool to help with deprescribing. (x6)
I will use medstopper.com to help evaluate my patients’ med lists. (x5)
I will evaluate patient medication lists with a tool at least once a year.
I will include a deprescribing plan in the patient chart.
I will try using the GP-GP on at least 3 patients in the next 3 months.
I will discuss deprescribing with patients during Annual Wellness Exams (x3).
I will try harder to emphasize the importance of deprescribing with families.
I will discontinue unnecessary medications.
I will talk to my patients about discontinuing medicines.
I will learn more about recommendations for deprescribing particular medications.
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Appendix Q
Feedback
Relevant (on 1-10 scale)
9.4
Helpful (on 1-10 scale)
8.7
Most important/useful thing
The website (medstopper.com) (x2)
Useful to know that there are so many different lists of no go meds for our patients
That there is a new Beer's list
Reminder that we need to be thinking critically about med lists at least yearly
The tools
The list of questions (GP-GP) to ask about medicines. Often meds do not have associated
indications and we should be reviewing charts to see fi indications exist.
Added
More case studies (2)
Time to discuss specific situations with our patients
Discussion of strategies for patients/families who are resistant to changes
How to tie med discussions in with ACP discussions since we are already doing these yearly
Is there a website like the one presented that has a version with U.S. drugs?
Subtracted
The information on the risks of polypharmacy…we already know this
The hypothetical case. Would have maybe been more useful to go through the med list of
an actual patient
"nothing" or blank x5

